Dinutuximab beta 20mg/4.5ml solution for infusion vials
- SNOMED code
35655711000001106- Active compound
- Dinutuximab beta
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 4.5 ml, vial
- Ingredients
- Dinutuximab beta
— 4.5 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Qarziba 20mg/4.5ml concentrate for solution for infusion vials (Recordati UK Ltd)
in short Qarziba 20mg/4.5ml concentrate for inf vials
Qarziba 20mg/4.5ml concentrate for solution for infusion vials
- SNOMED code
35655911000001108- Supplier
- Recordati UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Qarziba 20mg/4.5ml concentrate for solution for infusion vials (Recordati UK Ltd) 1 vial35656011000001100 ref. pack | 💯 Available Legal category: POM | 5060146291736End: 5060146293013 | NHS Indicative Price £7,610 | • Hospital |
| — |
Reference packs
Dinutuximab beta 20mg/4.5ml solution for infusion vials 1 vial
- SNOMED code
35655811000001103- Quantity and unit
- 1 vial
- Packs